✦ LIBER ✦

274 Mesalazine and/or Lactobacillus Casei in Maintaining Remission of Symptomatic Uncomplicated Diverticular Disease of the Colon: A Randomised, Double-Blind, Placebo-Controlled Study

✍ Scribed by Tursi, Antonio; Brandimarte, Giovanni; Elisei, Walter; Giorgetti, GianMarco; Forti, Giacomo; Rodino, Stefano; Sacca, Natale; D'Amico, Teresa; Portincasa, Piero; Lecca, Piera Giuseppina; Di Cesare, Luigi; Picchio, Marcello; Danese, Silvio

Book ID: 122298802
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 150 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)60220-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.12.9 MESALAZINE AND/OR LACTOBACILLUS C

P.12.9 MESALAZINE AND/OR LACTOBACILLUS CASEI IN MAINTAINING REMISSION OF SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

✍ Tursi, A.; Brandimarte, G.; Elisei, W.; Giorgetti, G.; Forti, G.; Rodinò, S.; Sa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Randomised clinical trial: mesalazine an

Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - a double-blind, randomised, placebo-controlled study

✍ Tursi, A.; Brandimarte, G.; Elisei, W.; Picchio, M.; Forti, G.; Pianese, G.; Rod 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

Randomised clinical trial: mesalazine (S

Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon - a placebo-controlled study

✍ Kruis, W.; Meier, E.; Schumacher, M.; Mickisch, O.; Greinwald, R.; Mueller, R. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Efficacy of rifaximin in the treatment o

Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial

✍ C. PAPI; A. CIACO; M. KOCH; L. CAPURSO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

A phase III, double-blind, placebo-contr

A phase III, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of antegren (Natalizumab) in maintaining clinical response and remission in Crohn’s disease (ENACT-2)

✍ W. Sandborn; J.-F. Colombel; R. Enns; B. Feagan; S. Hanauer; I. Lawrance; R. Pan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Evaluation of the immune benefits of two

Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study

✍ Rizzardini, Giuliano; Eskesen, Dorte; Calder, Philip C.; Capetti, Amedeo; Jesper 📂 Article 📅 2011 🏛 Cambridge University Press 🌐 English ⚖ 128 KB